HLB , Ltd. EBIT

As of the most recent data (June 2026), 028300.KQ shows a EBIT of $-98B. That compares with $-90B in the prior-year period — down 8.8% year over year. That is below the Healthcare sector average of $99B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 028300.KQ's EBIT is now $-98B (was $-90B) — a 8.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether HLB , Ltd. is outperforming or lagging.

The Healthcare sector average EBIT is about $99B. HLB , Ltd. is at $-98B, which is lower that average. That is roughly 198.4% below the sector mean. Use the comparison chart on this page to see how 028300.KQ stacks up against individual peers as well.

Tracking 028300.KQ's ebit over time shows whether HLB , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $-98B That compares with $-90B in the prior-year period — down 8.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has HLB , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-98B) with ownership activity and broader fundamentals.